Skip to main content

Table 1 Characteristics of 87 patients with locoregional recurrent esophageal cancer

From: Survival benefit of re-irradiation in esophageal Cancer patients with Locoregional recurrence: a propensity score-matched analysis

Variables

Number

Percent

Age (years)

  < 65

58

66.7

  ≥ 65

29

33.3

KPS

 70–80

32

36.8

 >80

55

63.2

Gender

 Male

65

74.7

 Female

22

25.3

Smoking

 Yes

31

35.6

 No

56

64.4

Alcohol consumption

 Yes

15

17.2

 No

72

82.8

Primary tumor location

 Upper thoracic

34

39.1

 Middle and lower thoracic

53

60.9

Initial clinical stage

 I + II

23

32.9

 III

47

67.1

Initial treatment

 Surgery + adjuvant radio(chemo)therapy

11

12.6

 Definitive chemoradiotherapy

39

44.8

 Definitive radiotherapy

37

42.6

Pattern of recurrence

 Regional lymph node recurrence only

14

16.1

 Local failure

62

71.3

 Both

11

12.6

Radiation dose in the initial treatment (Gy)

  ≤ 50

12

13.8

  > 50

75

86.2

Recurrence-free interval (months)

  ≤ 12

38

43.7

  > 12

49

56.3

Chemotherapy after recurrence

 Yes

26

29.9

 No

61

70.1

Re-RT after recurrence

 Yes

39

44.8

 No

48

55.2

Treatment moditily after recurrence

 Re-RT only

20

23.0

 CRT only

7

8.0

 Re-RT concomitant chemotherapy

19

21.8

 Best supportive care

39

43.7

 Salvage total esophagectomy

3

3.4

  1. Abbreviation: Re-RT Re-irradiation, KPS Karnofsky performance status